Granules buys Auctus Pharma in Rs 100 crore dealHyderabad-based pharmaceutical firm Granules India has agreed to buy Auctus Pharma for about Rs 100 crore in an all-cash deal.
Granules India eyes Rs 1,000 cr turnover this fiscalMid-sized pharmaceutical company Granules India is eying to achieve Rs 1,000 crore of revenue during the current financial year 2013-14.
Granules eyes 25% growth in topline this fiscalGranules India expects to post a growth of nearly 25% in revenues this fiscal thanks to fresh capacities available from Rs 115 crore expans...
- High power costs to drag margins of pharma firms
Majority of Indian pharmaceutical companies fear pressure on profit margins by at least 300-400 basis points as Andhra Pradesh, which accou...
- Drug formulations pep up sector, but contract research spoils Q3 party
However, pharma companies mainly into formulations have managed to show strong growth, except for those who had operations in Germany and s...
- Rs 75 crores NCD issue will be completed before March 2010: Dishman Pharma
VVS Murthy, CFO, Dishman Pharmaceuticals & Chemicals Ltd, in an interview with ET Now informs that 75 crores NCD issue will be completed be...
- Pharma R&D offshoring wards off slowdown
Contract Research & Manufacturing (CRAM) business of pharma companies has picked up pace amidst global economic crisis.